Top Markets
#1 Zora Zora +30.17%
#2 AI XOVIA AI XOVIA +27.52%
#3 Full Moon Full Moon +18.73%
#4 0G 0G +18.64%
#5 Notcoin Notcoin +17.28%
#6 Wrapped NXM Wrapped NXM +12.33%
#7 rsERG rsERG +12.24%
#8 Axelar Axelar +11.71%
#9 Helium Helium +11.58%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +10.49%
Coin of the day
Zora Zora
설정
언어
한국어
통화
USD
테마
CTI BioPharma Corp. CTI BioPharma Corp.

CTI BioPharma Corp.

CTIC
주식 순위 #12599
CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery,... CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery, advancement, and commercialization of innovative, targeted treatments for blood cancers within the United States. Its key product is VONJO (pacritinib), an oral kinase inhibitor currently under investigation, specifically designed to target JAK2, FLT3, IRAK1, and CSF1R for the management of adult patients with myelofibrosis. The company holds licensing and collaboration agreements with Teva Pharmaceutical Industries Ltd., SBIO Pte Ltd., and Baxalta. Established in 1991 and based in Seattle, Washington, CTI BioPharma Corp. was previously known as Cell Therapeutics, Inc., adopting its current name in May 2014.
주가
$9.09
마지막 동기화: 2023-06-23
시가총액
$567.77M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 CTI BioPharma Corp. (CTIC)

카테고리

Healthcare
CTI BioPharma Corp. (CTIC)의 배당 수익률 기록
CTI BioPharma Corp. (주식 심볼: CTIC)의 배당 수익률 (TTM)은 2026 기준으로 0입니다.
지난 5년 평균 배당 수익률: 0.00%
CTI BioPharma Corp. (CTIC)의 배당 수익률 기록: 2026 ~ 2026
연도별 말 기준 배당 수익률 (TTM)
연도 배당 수익률 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 배당 수익률 (TTM)
회사 배당 수익률 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH